Zimmer should report stronger than expected Q4 results, says Needham Needham expects Zimmer to benefit from the improving recon market, and gain share in that market. The firm keeps a Top Pick rating on the stock.
Zimmer Acquires bone void filler maker ETEX Holdings Zimmer Holdings announced that it has acquired the business of ETEX Holdings. The financial terms of the transaction were not disclosed. The acquisition enhances Zimmer's Biologics portfolio of treatments through the addition of ETEX's Beta-bsm, CarriGen, EquivaBone, and Gamma-bsm bone void filler products.